4//SEC Filing
XEROX CORP 4
Accession 0001127602-14-005297
CIK 0000108772operating
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 2:49 PM ET
Size
8.4 KB
Accession
0001127602-14-005297
Insider Transaction Report
Form 4
XEROX CORPXRX
BLODGETT LYNN
Executive Vice President
Transactions
- Sale
Common Stock
2014-02-06$10.35/sh−660,886$6,840,633→ 202,967 total - Exercise/Conversion
Stock Options
2014-02-06−660,886→ 0 totalExercise: $7.33From: 2010-02-05Exp: 2014-07-30→ Common Stock (660,886 underlying) - Exercise/Conversion
Common Stock
2014-02-06$7.33/sh+660,886$4,844,294→ 863,853 total
Footnotes (2)
- [F1]Weighted average price of shares sold. Share were sold in the range of $10.30 - $10.41.
- [F2]These options vest and become excercisable as follows: on each anniversary date of the grant, commencing with the first such anniversary date and continuing on each such anniversary thereafter through and including the fifth anniversary of the date of the grant, 20% of such options shall vest and become excercisable. The date of the grant is 10 years prior to the stated expiration date.
Documents
Issuer
XEROX CORP
CIK 0000108772
Entity typeoperating
IncorporatedCT
Related Parties
1- filerCIK 0000108772
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 2:49 PM ET
- Size
- 8.4 KB